Sai Parenteral’s IPO GMP, Open Date, Price Band, Issue Size

Sai Parenteral’s IPO open date is March 24, 2026, and the closing date is March 27, 2026. This new IPO is a book-built issue of 1,04,28,288 equity shares aggregating up to Rs 409 crore. This upcoming IPO consists of a fresh issue of 72,70,408 equity shares aggregating up to Rs 285 crore and an offer for sale of 31,57,880 equity shares aggregating up to Rs 124 crore.

Sai Parenteral’s IPO price band is Rs 372 to Rs 392 per share. As of March 20, 2026, the Sai Parenteral’s IPO GMP Live quotation is at Rs 0 (0.00%) per share. Live IPO Grey Market Premium details will be available online.

Sai Parenteral’s IPO allotment status will be available on March 30, 2026. Sai Parenteral’s IPO lot size is 38 shares. The minimum investment for retail investors for 1 lot is Rs 14,896. The registrar for the Sai Parenteral’s IPO is Bigshare Services Pvt Ltd. Sai Parenteral’s IPO listing date is April 2, 2026.

Also Read | Amir Chand Jagdish Kumar (Exports) IPO GMP, Open Date, Price Band

Sai Parenteral’s IPO GMP

Sai Parenteral’s IPO GMP is Rs 0 (0.00%) per share as on March 20, 2026. The IPO GMP today indicates neutral interest among retail and HNI investors. You can check the latest IPO Grey Market Premium online from the first day of subscription. If the subscription is oversubscribed, then Sai Parenteral’s IPO GMP might rise.

Sai Parenteral’s IPO Open Date, Close Date

Sai Parenteral’s IPO open date is March 24, 2026, and the IPO close date is March 27, 2026. The initiation of the refund date is April 1, 2026, and the credit of shares will be on April 1, 2026.

Sai Parenteral’s IPO Price Band

Sai Parenteral’s IPO price band is Rs 372 to Rs 392 per share. The minimum amount of investment for the retail category is Rs 14,896, and for small HNI, the minimum investment is Rs 2,08,544. The minimum investment for the Big HNI is Rs 10,12,928.

Sai Parenteral’s IPO Issue Size

Sai Parenteral’s IPO is a book-built issue of 1,04,28,288 equity shares aggregating up to Rs 409 crore. The issue comprises a fresh issue of 72,70,408 equity shares aggregating up to Rs 285 crore and an offer for sale of 31,57,880 equity shares aggregating up to Rs 124 crore.

Sai Parenteral’s IPO Allotment Status

Sai Parenteral’s IPO allotment status will be available on March 30, 2026. The listing will be on the BSE and NSE platforms. The registrar of this IPO is Bigshare Services Pvt Ltd. Investors can check their allotment status after the subscription ends.

Sai Parenteral’s IPO Listing Date

Sai Parenteral’s IPO listing date is April 2, 2026. The listing will be on the BSE and NSE platforms. Retail investors can sell the shares after 10 AM on the listing day.

Sai Parenteral’s IPO: Listing Date, Lot Size, Price Band

Sai Parenteral’s Limited: About the Company

Sai Parenterals Limited is a diversified pharmaceutical formulations company engaged in the research, development, and manufacturing of a wide range of medicines for both domestic and international markets. Incorporated on 12 January 2001, the company has built its presence around two core business segments: branded generic formulations and contract development and manufacturing organisation (CDMO) services. Its product portfolio spans multiple therapeutic areas such as cardiovascular, neuropsychiatry, anti‑diabetic, respiratory health, antibiotics, gastroenterology, vitamins and supplements, analgesics, and dermatology. The company manufactures medicines across various dosage forms, including injectables, tablets, capsules, liquid orals, and ointments, through in‑house research as well as strategic asset acquisitions.

Sai Parenterals Limited operates multiple manufacturing facilities in India, with a strong foothold in Hyderabad, Telangana, and another site through its subsidiary in Ongole, Andhra Pradesh. These units are aligned with regulatory standards and support both branded‑generic sales to government agencies, hospitals, pharma companies, and distributors in India, as well as export‑oriented CDMO and formulations business to regulated and semi‑regulated markets across Australia, New Zealand, Southeast Asia, the Middle East, and Africa. The company’s focus on critical‑care injectables and sterile formulations, along with a diversified therapeutic mix, underpins its role in India’s evolving pharmaceutical value chain.

Sai Parenteral’s IPO Objectives

Sai Parenteral’s proposes to utilise the net proceeds from the issue towards funding capital expenditure requirements, supporting working capital needs, and general corporate purposes.

Sai Parenteral’s IPO: Key Dates, Allotment, Listing Date

Sai Parenteral’s Limited Financials (Amt in Rs Cr)

Sai Parenteral’s IPO Lot Size Details

Sai Parenteral’s IPO lot size is 38 shares. The minimum investment for the retail category is Rs 14,896, and for small HNI, the minimum investment is Rs 2,08,544.

Sai Parenteral’s IPO Promoter Holdings

The promoter shareholding before the IPO is 61.23%. Post issue shareholding will dilute after the fresh issue and OFS.

Sai Parenteral’s IPO Registrar

Sai Parenteral’s IPO registrar is Bigshare Services Pvt Ltd. Investors can check their allotment status on the registrar’s website using their PAN or application ID.

How to Apply to the Sai Parenteral’s IPO

Investors can apply to the Sai Parenteral’s IPO through the Bigul trading app or by visiting the website. You can also check details of other upcoming IPOs listed on Bigul.

Sai Parenteral’s IPO FAQ

1. What are the details of the Sai Parenteral’s IPO?

Sai Parenteral’s IPO is a book-built issue of 1,04,28,288 equity shares aggregating up to Rs 409 crore. The issue comprises a fresh issue and an offer for sale.

2. When will the Sai Parenteral’s IPO open and close?

Sai Parenteral’s IPO open date is March 24, 2026, and the IPO close date is March 27, 2026. The initiation of the refund date is April 1, 2026, and the credit of shares will be on April 1, 2026.

3. What is Sai Parenteral’s IPO GMP?

Sai Parenteral’s IPO GMP is Rs 0 (0.00%) as on March 20, 2026.

4. Write the details of the IPO Allotment Status.

Sai Parenteral’s IPO allotment status will be available on March 30, 2026. The listing will be on the BSE and NSE platforms. The registrar of this IPO is Bigshare Services Pvt Ltd.

5. Who is the registrar and the lead managers for Sai Parenteral’s IPO?

The registrar is Bigshare Services Pvt Ltd. The lead manager is Arihant Capital Markets Ltd.

Also Read | Powerica IPO GMP, Open Date, Price Band, Issue Size